- Lobbying
- Lobbying by PFIZER, INC
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Alexander Dahl | Dep. Staff Dir-Sr. Counsel-Senate Judiciary Comm, Sr. Counsel - Senate Judiciary Committee, Counsel - Senate Judiciary Committee |
Makan Delrahim | Deputy Asst. AG-Anti-Trust Div.-Dept. of Justice, Chf Counsel & Staff Dir. - Senate Judiciary Comm, Counsel - U.S. Senate - Judiciary Committee |
Marc Lampkin | Policy Dir.-Senate Republican Conf. Sectys office, General Counsel - House Republican Conference, Staff/Counsel - House Education and Labor Comm. |
William Moschella | PrinAssocDepAG DOJ,AsstAG DOJ,ChfLegCouns/Parliam Hs JudicComm,ChfInvestigativeCouns Hs Judic Comm, GC Hs Rule Comm,Couns Hs Judic Comm,Couns/Parliam Hs Gov Rel Comm, SrLegAssst Rep Frank Wolf,LegAsst Rep Frank Wolf,ComputerSysManager Rep Frank Wolf |
Neil Quinter | Chief Counsel - Senator Dianne Feinstein, Minority Chief Counsel and Staff Director, Subcommittee on Technology, Terrorism and Government Information, Senate Judiciary Committee, Counsel, Senator Dianne Feinstein |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Antitrust issues associated with proposed merger between Pfizer and Allergan.
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate